FILTER
Prikaži samo sadržaje koji zadovoljavaju:
objavljeni u periodu:
na jeziku:
hrvatski engleski
sadrže pojam:

SPOKESWOMAN: PATIENTS' SAFETY AND SECURITY IS BAXTER'S MAIN CONCERN

WASHINGTON, Oct 18 (Hina) - The management of the US company "Baxter", whose dialysers are believed to be the cause of the sudden death of 21 kidney patients in Croatian hospitals, on Wednesday asserted that it regarded the safety and security of people as its primary task. Corroborating this statement, a spokeswoman for this company, Tanya Tyska, said Baxter had set up an independent team of experts, who should work together with Croatia's authorities in a comprehensive investigation into those tragic events. The team of experts is led by an eminent nephrologist, Professor Bernard Canaud, from Montpellier, France, and other members are professors from well-known European universities and hospitals, and representatives of a German company, TuV Product Service, Tyska told Hina. She denied a report recently published by a Croatian daily, which claimed that Baxter had negotiated with Pliva, Croatia's l
WASHINGTON, Oct 18 (Hina) - The management of the US company "Baxter", whose dialysers are believed to be the cause of the sudden death of 21 kidney patients in Croatian hospitals, on Wednesday asserted that it regarded the safety and security of people as its primary task. Corroborating this statement, a spokeswoman for this company, Tanya Tyska, said Baxter had set up an independent team of experts, who should work together with Croatia's authorities in a comprehensive investigation into those tragic events. The team of experts is led by an eminent nephrologist, Professor Bernard Canaud, from Montpellier, France, and other members are professors from well-known European universities and hospitals, and representatives of a German company, TuV Product Service, Tyska told Hina. She denied a report recently published by a Croatian daily, which claimed that Baxter had negotiated with Pliva, Croatia's leading drugs firm and importer of Baxter's controversial dialysers, on joint investment in a plant for manufacturing infusion solutions outside Zagreb. We did not discuss any joint investment with Pliva, Tyska said describing the daily's allegations as rumours to which it was not appropriate to respond. Baxter's management also refuted assertions that this corporation held Pliva's shares, about which some Croatian media speculated. (hina) ms

VEZANE OBJAVE

An unhandled error has occurred. Reload 🗙